Analyst
Truist Securities
Equibles does not estimate personal net worth.
Les Sulewska is recorded as Analyst at Truist Securities. Les Sulewska has spoken on 2 earnings calls across 2 companies, most recently for Teva Pharmaceutical Industries Ltd on November 5, 2025. Those appearances were for Teva Pharmaceutical Industries Ltd (TEVA) and Amneal Pharmaceuticals, Inc. (AMRX). The companies whose calls Les Sulewska spoke on are classified in the Healthcare sector.
“So, we saw the FDA propose new guidance around biosimilars to reduce comparative efficacy study and, you know, potentially speed up the approval process. So, three questions on this for you.”
“Can you provide any latest commentary around Nalaxone? Any additional contracts that you sign with other states? And then, second, I haven't really heard much commentary on Unithroid.”
Truist Securities
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
